| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Mycobacterium Infections | D009164 | 7 associated lipids |
| Kidney Neoplasms | D007680 | 29 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Mammary Neoplasms, Experimental | D008325 | 67 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Esophageal Neoplasms | D004938 | 20 associated lipids |
| Precancerous Conditions | D011230 | 48 associated lipids |
| Carbon Tetrachloride Poisoning | D002252 | 12 associated lipids |
| Femoral Neck Fractures | D005265 | 3 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Heart Failure | D006333 | 36 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ohnhaus EE et al. | Enzyme induction and renal function in man. | 1977 | Br J Clin Pharmacol | pmid:843422 |
| Edwards JW and Priestly BG | Sister chromatid exchanges in lymphocytes of petroleum retailers. | 1993 | Br J Ind Med | pmid:8435347 |
| Breimer DD et al. | Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. | 1977 | Clin. Pharmacol. Ther. | pmid:849678 |
| Abou-Issa H et al. | Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination. | 1993 Mar-Apr | Anticancer Res. | pmid:8517653 |
| Tsuruoka T et al. | Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). | 1995 | Jpn. J. Cancer Res. | pmid:8567400 |
| Weiersmüller A et al. | The influence of prednisolone on hepatic function in normal subjects. Effects on galactose elimination capacity, sulfobromophthalein transport maximum and storage capacity, and D-glucaric acid output. | 1977 | Am J Dig Dis | pmid:857663 |
| Meier JR et al. | Urine mutagenicity and biochemical effects of the drinking water mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX), following repeated oral administration to mice and rats. | 1996 | Toxicology | pmid:8658560 |
| Silverberg DS et al. | Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. | 1996 | Am. J. Kidney Dis. | pmid:8659499 |
| Cassimos C et al. | Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. | 1977 | Acta Paediatr Scand | pmid:868519 |
| Collinot JP et al. | Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol. | 1996 | J Toxicol Environ Health | pmid:8691506 |
| Mercuriali F | Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. | 1996 | Semin. Hematol. | pmid:8723574 |
| Mercuriali F | Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia. | 1996 | Semin. Hematol. | pmid:8723576 |
| Tryba M | Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery. | 1996 | Semin. Hematol. | pmid:8723577 |
| Sung RY et al. | Urinary D-glucaric acid excretion in idiopathic neonatal jaundice. | 1996 | Chin. Med. J. | pmid:8758309 |
| Meyer MP et al. | A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. | 1996 | J. Pediatr. | pmid:8765624 |
| Fujihira E and Whitehouse MW | Pathobiodynamics: reduced ascorbate excretion by rats with severe inflammation. | 1977 | Proc. Soc. Exp. Biol. Med. | pmid:877135 |
| Addyman R et al. | Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs. | 1996 | Ann. Rheum. Dis. | pmid:8774168 |
| Moretti M et al. | Biological monitoring of genotoxic hazard in workers of the rubber industry. | 1996 | Environ. Health Perspect. | pmid:8781380 |
| Kawasaki H et al. | Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis. | 1977 | Acta Hepatogastroenterol (Stuttg) | pmid:883466 |
| Monarca S et al. | Biological monitoring of workers exposed to N-nitrosodiethanolamine in the metal industry. | 1996 | Environ. Health Perspect. | pmid:8834865 |
| Silverberg DS et al. | Intravenous ferric saccharate as an iron supplement in dialysis patients. | 1996 | Nephron | pmid:8852489 |
| Lorincz M et al. | Enzyme-generated intracellular fluorescence for single-cell reporter gene analysis utilizing Escherichia coli beta-glucuronidase. | 1996 | Cytometry | pmid:8866216 |
| Brunelle FM and Verbeeck RK | Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. | 1996 | Xenobiotica | pmid:8867997 |
| Talafant E et al. | Negative feedback control of neonatal serum creatine and increased urinary creatinine excretion after enzyme-inducing drugs. | 1977 | Pediatr. Res. | pmid:887306 |
| pmid:8902444 | ||||
| Sunder-Plassmann G and Hörl WH | Safety of intravenous injection of iron saccharate in haemodialysis patients. | 1996 | Nephrol. Dial. Transplant. | pmid:8918625 |
| Bisio S and Franco G | Drinking habits and occupational exposure to xenobiotics: a review. | 1995 Jan-Nov | G Ital Med Lav | pmid:8940655 |
| Rost KL et al. | Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment. | 1997 | Int J Clin Pharmacol Ther | pmid:9021436 |
| Roth B et al. | [Excretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)]. | 1977 | Padiatr Padol | pmid:904946 |
| Drzewiecki J | Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction. | 1977 Jul-Aug | Pol J Pharmacol Pharm | pmid:905203 |
| Walaszek Z et al. | Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. | 1997 | Cancer Detect. Prev. | pmid:9101079 |
| Petrov AD et al. | Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. | 1997 | Nucl Med Commun | pmid:9106778 |
| Narula J et al. | Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. | 1997 | Circulation | pmid:9118528 |
| Furuno K et al. | Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. | 1977 | Jpn. J. Pharmacol. | pmid:916384 |
| Brunelle FM and Verbeeck RK | Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat. | 1997 | Life Sci. | pmid:9180355 |
| Scassellati-Sforzolini G et al. | In vivo studies on genotoxicity of pure and commercial linuron. | 1997 | Mutat. Res. | pmid:9186570 |
| Narula J et al. | Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells. | 1997 | Chest | pmid:9187194 |
| Miguel JC et al. | Effects of iron salts in sucrose on dental caries and plaque in rats. | 1997 | Arch. Oral Biol. | pmid:9233847 |
| Sunder-Plassmann G et al. | The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures. | 1997 | Nephrol. Dial. Transplant. | pmid:9269632 |
| Beanlands RS et al. | Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. | 1997 Jul-Aug | J Nucl Cardiol | pmid:9278873 |
| Khaw BA et al. | Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. | 1997 Jul-Aug | J Nucl Cardiol | pmid:9278874 |
| pmid:9278881 | ||||
| Hildebrandt AG et al. | Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo. | 1975 | Eur. J. Clin. Pharmacol. | pmid:9297 |
| Cynke E | [Parenteral iron replacement]. | 1997 | Praxis (Bern 1994) | pmid:9312810 |
| Furuno K et al. | Effect of D-Glucarates on basic antibiotic-induced renal damage in rats. | 1976 | J. Antibiot. | pmid:931801 |
| Sunder-Plassmann G and Hörl WH | Safety aspects of parenteral iron in patients with end-stage renal disease. | 1997 | Drug Saf | pmid:9352960 |
| Cazzola M | Recombinant human erythropoietin to assist autologous blood donation by patients with anemia. | 1997 | J. Lab. Clin. Med. | pmid:9358072 |
| Sandle LN et al. | Indirect evidence for hepatic induction in patients with cholesterol gallstones. | 1997 | Biochem. Soc. Trans. | pmid:9388642 |
| al-Hawas F et al. | Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin. | 1997 | Nephrol. Dial. Transplant. | pmid:9430909 |
| Kuramitsu Y et al. | A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. | 1998 | Anticancer Drugs | pmid:9491797 |